Form 10-Q ZS Pharma, Inc. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
ZS Pharma (ZSPH) Posts Q2 Loss of $4.72/Share
August 14, 2014 4:53 PM EDTZS Pharma (NASDAQ: ZSPH) reported Q2 EPS of ($4.72), $4.06 worse than the analyst estimate of ($0.66).
For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.
... More


